In some tumor types such as ovarian, prostate, and colorectal cancer, Th17 cells induce an antitumor immune response by recruiting cytotoxic effector T cells and producing effector cytokines, including interferon-gamma (Kryczek et al., 2009; Tosolini et al., 2011). This evidence concerns the gene IFNG and neoplasm.